
Members of the ACIP voted on Friday to recommend Pfizer’s maternal bivalent RSVpreF vaccine to protect newborns from severe RSV illness.

Sydney Jennings is the editor of Patient Care Online. She joined MJH Life Sciences in March 2018 after graduating from the University of Connecticut with a BA in Journalism. She can be reached at [email protected].

Members of the ACIP voted on Friday to recommend Pfizer’s maternal bivalent RSVpreF vaccine to protect newborns from severe RSV illness.

Your daily dose of the clinical news you may have missed.

Empagliflozin is approved to lower the risk of sustained decline in eGFR, end-stage kidney disease, CV death, and hospitalization in adults with CKD at risk of progression.

Your daily dose of the clinical news you may have missed.

What state has highest share of adult depression? Or the lowest divorce rate? Find the answers and more insights from a nationwide analysis, here.

Your daily dose of the clinical news you may have missed.

An intensive parent-support early childhood obesity intervention program led to better weight status outcomes in the long-term compared to standard therapy, report study authors.

Your daily dose of the clinical news you may have missed.

Obesity specialist Sandra Christensen, MSN, ARNP, compares the benefits and drawbacks among older antiobesity drugs and newer GLP-1RAs liraglutide and semaglutide 2.4 mg.

Your daily dose of the clinical news you may have missed.

Results from a new study show that older adults with untreated hypertension had a 42% increased risk of dementia vs healthy controls.

Your daily dose of the clinical news you may have missed.

Your daily dose of clinical news you may have missed.

Obesity specialist Sandra Christensen, MSN, ARNP, details the differences between older antiobesity medications and newer GLP-1RAs liraglutide and semaglutide 2.4 mg.

Your daily dose of clinical news you may have missed.

New research presented at Hypertension 2023 showed a novel digital bilingual hypertension control program improved BP control rates by more than 30%.

Your daily dose of clinical news you may have missed.

Persons with HTN while in a supine position had a higher risk for CVD even if they did not have HTN while seated, according to new research presented at Hypertension 2023.

Your daily dose of clinical news you may have missed.

Your daily dose of clinical news you may have missed.

Results from a new study suggest that postnatal SSRI treatment may be beneficial in the long term for both women with postpartum depression and their children.

Your daily dose of clinical news you may have missed.

Vaccination against SARS-CoV-2 may decrease the symptoms of post-COVID conditions, such as abdominal pain and weakness, according to new study.

Listen to our latest podcast episode for details on top CVD risk factors to screen patients with obesity for, medications to help prevent CVD, and more.

Your daily dose of clinical news you may have missed.

ESC 2023: New data showed an aspirin-free strategy after PCI did not reduce major bleeding event risk vs DAPT, while omission of aspirin proved noninferior for CV events in high-risk patients.

Your daily dose of clinical news you may have missed.

ESC 2023: Early initiation of dapagliflozin did not result in a statistically significant improvement in diuretic efficiency relative to structured usual care in patients hospitalized with ADHF.

A daily dose of clinical news on Patient Care you may have missed.

Findings from a recent study show a broad spectrum of possible clinical manifestations of IRD following SARS-CoV-2 infection or COVID-19 vaccination.